Nutanix Reports First Quarter Fiscal 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Wall Street ends down as US-Iran peace optimism fades
- S&P 500 EPS growth above 20% is rare. Why 2027 may be at risk
- Goldman Sachs warns AI investment may be crowding out other business spending
- Why Wednesday's inflation print could provide the next dovish catalyst
- Tesla needs Robotaxi flywheel proof to boost investor conviction: Morgan Stanley
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- Wall Street ends down as US-Iran peace optimism fades
- eToro to acquire TradeZero for up to $231M to expand in US
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
Nutanix (NTNX) PT Raised to $38 at Oppenheimer
November 30, 2016 9:50 AM ESTOppenheimer analyst Ittai Kidron reiterated an Outperform rating and lifted his price target on Nutanix (NASDAQ: NTNX) to $38.00 (from $36.00) following a strong quarter out of the gate as a public company.
Kidron commented, "Nutanix delivered a strong first quarter as a... More
Susquehanna Remains Sidelined on Nutanix (NTNX) - PT to $29
November 30, 2016 7:55 AM ESTSusquehanna reiterated a Neutral rating on Nutanix (NASDAQ: NTNX), and raised the price target to $29.00 (from $24.00), following the company's 1Q earnings report. Management noted that its stronger top-line results were driven by stronger than expected Federal business.
Analyst Mehdi Hosseini commented, "We came away encouraged with NTNX's strong October-quarter top-line results and January-quarter guide - as well as promising cash flow dynamics; however, we remain Neutral at current levels given the confluence of appropriate valuation, potential... More
Needham & Company Reiterates Buy on Nutanix (NTNX) Following 1Q Report
November 30, 2016 7:33 AM ESTNeedham & Company reiterated a Buy rating and $36.00 price target on Nutanix (NASDAQ: NTNX) following the company's 1Q earnings report. NTNX posted revenue of $166.8M and a non-GAAP loss per share of ($0.37) vs. consensus estimates of $152.3M and ($0.44).
Analyst Richard Kugele commented,... More
